Kezdőlap・Részvénylista・Hims & Hers Health Inc

Hims & Hers Health Inc

Nyitva

SzektorVédekező fogyasztói cikkek

32.07 4.09

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

30.24

Maximum

31.73

Fő mutatók
By Trading Economics
Bevétel	-113M -92M
Értékesítés	-9.7M 608M
P/E Szektor átlag	57.137 33.699
Egy részvényre jutó nyereség	-0.19
Profit margin	-15.148
Munkavállalók	2,442
EBITDA	-107M -80M

Ajánlások
By TipRanks
Ajánlások	Vétel
12 hónapos előrejelzés	-3.05% downside

Osztalékok
By Acuity
Következő eredményjelentés	2026. aug. 10.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	266M 7B
Előző nyitás	27.98
Előző zárás	32.07

Hangulat hírek alapján

By Acuity

50%

52 / 130 Rangsor szerint Consumer defensive

Hims & Hers Health Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 3. 23:41 UTC

News

Hims & Hers Health shares are higher in after-market trading, following positive growth insights despite facing a lawsuit from the Federal Trade Commission.

2026. júl. 31. 19:36 UTC

Social Media

News

Hims & Hers Health Inc is trading higher amid social media discussions about potential undervaluation, despite facing a lawsuit over user health data practices.

2026. júl. 30. 20:11 UTC

Hims & Hers Health Inc shares are higher today amid high trading volume. Broader economic data showed mixed signals, contributing to market volatility.

2026. júl. 29. 23:16 UTC

Social Media

News

Hims & Hers Health shares declined in after-market trading amid legal challenges from the FTC over alleged privacy violations and a securities fraud investigation.

2026. júl. 28. 23:41 UTC

Hims & Hers Health shares declined in after-market trading, remaining near the lower end of their one-month range amid broader market pressures from Asian tech losses.

2026. júl. 27. 20:03 UTC

News

Social Media

Hims & Hers Health shares rise amid FDA committee's endorsement of peptides, seen as a significant step toward market access for treatments.

2026. júl. 24. 23:16 UTC

Social Media

Hims & Hers Health Inc. shares rose after-hours following positive votes from an FDA/HHS panel on six peptides, with a final decision expected in up to 12 months.

2026. júl. 23. 23:26 UTC

News

Hims & Hers Health Inc shares are higher after an FDA advisory panel recommended easing restrictions on a popular peptide and Canaccord reiterated a Buy rating.

2026. júl. 22. 23:16 UTC

News

Hims & Hers Health shares declined to about $31.66 after mixed options sentiment, with calls outpacing puts amid lighter trading volume.

2026. júl. 21. 17:31 UTC

News

Hims & Hers Health Inc shares are declining amid an investigation into potential wrongdoing and concerns over FDA approval of key peptides.

2026. júl. 20. 18:37 UTC

News

Hims & Hers Health Inc. is trading higher amid broader market dynamics, despite earlier pulling back from a session high.

Társak összehasonlítása

Árváltozás

Hims & Hers Health Inc Előrejelzés

Célár

By TipRanks

-3.05% elmozdulás lefelé

12 hónapos előrejelzés

Átlag 29.88 USD -3.05%

Magas 40 USD

Alacsony 21 USD

13 Wall Street elemző 12 hónapos célárain alapulva a(z)Hims & Hers Health Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

13 ratings

Vétel

Tartás

Eladás

13 Wall Street elemző célárain alapulva a(z)Hims & Hers Health Inc termékhez az elmúlt 3 hónapban.

Hangulat

By Acuity

52 / 130 Rangsor szerint Védekező fogyasztói cikkek

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.